Raymond James Financial Services Advisors’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-23,475
| Closed | -$60.1K | – | 3372 |
|
|
2023
Q1 | $60.1K | Buy |
+23,475
| New | +$60.1K | ﹤0.01% | 3106 |
|
|
2022
Q4 | – | Sell |
-22,311
| Closed | -$39K | – | 3335 |
|
|
2022
Q3 | $39K | Hold |
22,311
| – | – | ﹤0.01% | 3097 |
|
|
2022
Q2 | $29K | Hold |
22,311
| – | – | ﹤0.01% | 3110 |
|
|
2022
Q1 | $53K | Hold |
22,311
| – | – | ﹤0.01% | 3163 |
|
|
2021
Q4 | $102K | Sell |
22,311
-7,950
| -26% | -$36.3K | ﹤0.01% | 3104 |
|
|
2021
Q3 | $245K | Hold |
30,261
| – | – | ﹤0.01% | 2829 |
|
|
2021
Q2 | $297K | Buy |
30,261
+1,000
| +3% | +$9.82K | ﹤0.01% | 2727 |
|
|
2021
Q1 | $258K | Buy |
29,261
+700
| +2% | +$6.17K | ﹤0.01% | 2727 |
|
|
2020
Q4 | $292K | Hold |
28,561
| – | – | ﹤0.01% | 2479 |
|
|
2020
Q3 | $258K | Hold |
28,561
| – | – | ﹤0.01% | 2367 |
|
|
2020
Q2 | $204K | Buy |
+28,561
| New | +$204K | ﹤0.01% | 2479 |
|